过敏原免疫治疗增强过敏性哮喘患者气道上皮抗病毒免疫:VITAL双盲随机对照试验
HDM-SLIT组支气管上皮细胞在poly(I:C)刺激后IFN-β基因(P=0.009)和蛋白(P=0.02)表达增加,IFN-λ基因表达亦增加(P=0.03),提示HDM-SLIT改善支气管上皮抗病毒抵抗力。
要点
- HDM-SLIT可增强过敏性哮喘患者支气管上皮细胞IFN-β和IFN-λ表达。
- HDM-SLIT组促炎因子IL-6较基线升高(P=0.009),TNF-α有升高趋势(P=0.08)。
- TSLP、IL-4、IL-13和IL-10无显著变化。
核心结论
- HDM-SLIT改善支气管上皮对病毒感染的抗病毒抵抗力,可能解释其减少过敏性哮喘急性发作的疗效。
研究设计与样本
- 双盲随机对照试验(VITAL),成人屋尘螨过敏性哮喘患者接受HDM-SLIT 12-SQ或安慰剂24周。
- 基线和第24周行支气管镜检查采集人支气管上皮细胞,体外以poly(I:C)刺激,qRT-PCR测mRNA,多因子ELISA测蛋白。
主要发现
- HDM-SLIT组poly(I:C)诱导的IFN-β基因表达增加(P=0.009),蛋白表达增加(P=0.02)。
- HDM-SLIT组IFN-λ基因表达增加(P=0.03),IL-33呈下降趋势(P=0.09)。
- HDM-SLIT组促炎因子IL-6较基线升高(P=0.009),TNF-α呈升高趋势(P=0.08)。
- TSLP、IL-4、IL-13和IL-10无显著变化。
临床怎么用
- 对于屋尘螨过敏性哮喘患者,HDM-SLIT可能通过增强气道上皮抗病毒免疫减少病毒诱发的急性发作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Allergic asthma is linked to impaired bronchial epithelial secretion of IFNs, which may be causally linked to the increased risk of viral exacerbations. We have previously shown that allergen immunotherapy (AIT) effectively reduces asthma exacerbations and prevents respiratory infections requiring antibiotics; however, whether AIT alters antiviral immunity is still unknown. Objectives: To investigate the effect of house dust mite sublingual AIT (HDM-SLIT) on bronchial epithelial antiviral and inflammatory responses in patients with allergic asthma. Methods: In this double-blind, randomized controlled trial (VITAL [The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients with Allergic Asthma]), adult patients with HDM allergic asthma received HDM-SLIT 12-SQ or placebo for 24 weeks. Bronchoscopy was performed at baseline and at Week 24, which included sampling for human bronchial epithelial cells. Human bronchial epithelial cells were cultured at baseline and at Week 24 and stimulated with the viral mimic polyinosinic:polycytidylic acid (poly(I:C)). mRNA expression was quantified using qRT-PCR, and protein concentrations were measured using multiplex ELISA. Measurements and Main Results: Thirty-nine patients were randomized to HDM-SLIT (n = 20) or placebo (n = 19). HDM-SLIT resulted in increased polyinosinic:polycytidylic acid-induced expression of IFN-β at both the gene (P = 0.009) and protein (P = 0.02) levels. IFN-λ gene expression was also increased (P = 0.03), whereas IL-33 tended to be decreased (P = 0.09). On the other hand, proinflammatory cytokines IL-6 (P = 0.009) and TNF-α (tumor necrosis factor-α) (P = 0.08) increased compared with baseline in the HDM-SLIT group. There were no significant changes in TSLP (thymic stromal lymphopoietin), IL-4, IL-13, and IL-10. Conclusions: HDM-SLIT improves bronchial epithelial antiviral resistance to viral infection. These results potentially explain the efficacy of HDM-SLIT in reducing exacerbations in allergic asthma. Clinical trial registered with www.clinicaltrials.gov (NCT04100902).
引用
- Woehlk C, Ramu S, Sverrild A, et al. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial. Am J Respir Crit Care Med. 2023. PMID: 36701676. doi:10.1164/rccm.202209-1708OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。